These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2670639)

  • 1. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients.
    Steffes MW; Osterby R; Chavers B; Mauer SM
    Diabetes; 1989 Sep; 38(9):1077-81. PubMed ID: 2670639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy.
    Matsubara T; Abe H; Arai H; Nagai K; Mima A; Kanamori H; Sumi E; Takahashi T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Lab Invest; 2006 Apr; 86(4):357-68. PubMed ID: 16482100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S; Nakamura T
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of kidney injury by basic fibroblast growth factor or platelet-derived growth factor does not induce progressive diabetic nephropathy in the Goto Kakizaki model of non-insulin-dependent diabetes.
    Riley SG; Steadman R; Williams JD; Floege J; Phillips AO
    J Lab Clin Med; 1999 Sep; 134(3):304-12. PubMed ID: 10482316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural-functional relationships in diabetic nephropathy.
    Mauer SM; Steffes MW; Ellis EN; Sutherland DE; Brown DM; Goetz FC
    J Clin Invest; 1984 Oct; 74(4):1143-55. PubMed ID: 6480821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A; Arai H; Matsubara T; Abe H; Nagai K; Tamura Y; Torikoshi K; Araki M; Kanamori H; Takahashi T; Tominaga T; Matsuura M; Iehara N; Fukatsu A; Kita T; Doi T
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renal hemodynamic basis of diabetic nephropathy.
    O'Bryan GT; Hostetter TH
    Semin Nephrol; 1997 Mar; 17(2):93-100. PubMed ID: 9148381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycemic control on early diabetic renal lesions. A 5-year randomized controlled clinical trial of insulin-dependent diabetic kidney transplant recipients.
    Barbosa J; Steffes MW; Sutherland DE; Connett JE; Rao KV; Mauer SM
    JAMA; 1994 Aug 24-31; 272(8):600-6. PubMed ID: 8057515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2012 Jan; 17(1):68-75. PubMed ID: 21933307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat.
    Soulis-Liparota T; Cooper M; Papazoglou D; Clarke B; Jerums G
    Diabetes; 1991 Oct; 40(10):1328-34. PubMed ID: 1834497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic nephropathy in insulin-dependent diabetes mellitus: pathogenesis and treatment strategies.
    Bilo HJ; Gans RO; Elving L; de Nobel E; Donker AJ
    Neth J Med; 1990 Feb; 36(1-2):74-85. PubMed ID: 2179753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role of mesangial dysfunction in the development of diabetic nephropathy.
    Shigeta Y; Kikkawa R
    Jpn J Med; 1991; 30(6):622-4. PubMed ID: 1798231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetes mellitus and its complications in Japan. The dysfunction of mesangial cells on pathogenesis of diabetic nephropathy].
    Shigeta Y; Kikkawa R
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1442-5. PubMed ID: 1761925
    [No Abstract]   [Full Text] [Related]  

  • 15. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes.
    Drummond K; Mauer M;
    Diabetes; 2002 May; 51(5):1580-7. PubMed ID: 11978659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Kidney Injury and Progression of Diabetic Kidney Disease.
    Yu SM; Bonventre JV
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):166-180. PubMed ID: 29580581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating fibronectin contributes to mesangial expansion in a murine model of type 1 diabetes.
    Klemis V; Ghura H; Federico G; Würfel C; Bentmann A; Gretz N; Miyazaki T; Gröne HJ; Nakchbandi IA
    Kidney Int; 2017 Jun; 91(6):1374-1385. PubMed ID: 28159318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
    Andrésdóttir G; Bakker SJ; Hansen HP; Parving HH; Rossing P
    Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease.
    Piccoli GB; Grassi G; Cabiddu G; Nazha M; Roggero S; Capizzi I; De Pascale A; Priola AM; Di Vico C; Maxia S; Loi V; Asunis AM; Pani A; Veltri A
    Rev Diabet Stud; 2015; 12(1-2):87-109. PubMed ID: 26676663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.